Why Thermo Fisher Scientific Stock Tumbled Today
Investors seemed unhappy about some major spending news from the company.
| Ticker |
SOLV
|
| CIK | 0001964738 |
| SIC | 3841 |
| Sector | Manufacturing |
| Industry Category | Medical Equipment |
| Industry Group | Surgical, Medical, And Dental Instruments And Supplies |
| Address | C/O 3M COMPANY, 3M CENTER, BUILDING 275-6W-02, ST. PAUL, MN, 55144-1000 |
| Website | www.solventum.com/en-us/home/ |
| Phone | 651-733-1110 |
| CEO | Bryan C. Hanson |
| Employees | 22,000 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Why Thermo Fisher Scientific Stock Tumbled TodayInvestors seemed unhappy about some major spending news from the company. Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration BusinessWALTHAM, Mass., September 02, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and Separation business, is part of the Life Sciences Solutions segment. Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.Solventum (NYSE: SOLV) today announced it has completed the sale of its Purification & Filtration business ("P&F") to Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") for $4.0 billion in cash before customary adjustments. Solventum’s $1.75 Billion Debt Buyback Could Be a Game Changer for SOLVOn August 22, 2025, Solventum Corporation announced it had begun cash tender offers to repurchase several series of its outstanding senior notes, targeting up to US$1.75 billion in aggregate purchase price across multiple maturities. This effort signals Solventum’s intent to actively manage its debt structure, which could bolster flexibility for future growth initiatives and support financial optimization. We’ll explore how this significant move to repurchase outstanding debt may reshape... Solventum to Participate in Upcoming Investor ConferencesSolventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences: |